EMA Application withdrawn: Feraheme (Ferumoxytol) — Covis Pharma Europe B.V.

View source ↗

Summary

EMA has withdrawn the application for Feraheme (ferumoxytol) by Covis Pharma Europe B.V. in the anemia/iron-deficiency indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

Status: Application withdrawn. Therapeutic area: Anemia, Iron-Deficiency. MAH: Covis Pharma Europe B.V.